This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (74) Citing Articles via Google Scholar Google Scholar Articles by Reuben, S. S. Articles by Sklar, J. Search for Related Content PubMed PubMed Citation Articles by Reuben, S. S. Articles by Sklar, J. Related Collections Ambulatory Pain

---

AMBULATORY ANESTHESIA

The Preemptive Analgesic Effect of Rofecoxib After Ambulatory Arthroscopic Knee Surgery

Department of Anesthesiology, Baystate Medical Center, Springfield, Massachussetts; and *New England Orthopedic Surgeons, P.C., Baystate Medical Center, Springfield, Massachussetts

Address correspondence and reprint requests to Scott S. Reuben, MD, Department of Anesthesiology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199. Address e-mail to scott.reuben{at}bhs.org

Nonsteroidal antiinflammatory drugs (NSAIDs) provide effective postoperative analgesia after arthroscopic knee surgery. Some investigators have suggested that the preemptive administration of NSAIDs may reduce postoperative analgesic requirements and hypersensitivity. We evaluated the analgesic effect of administering rofecoxib either before or after surgical incision in patients undergoing arthroscopic knee surgery under local anesthesia. Sixty patients undergoing arthroscopic meniscectomy were randomized into three groups. All patients received intraarticular bupivacaine 0.25% pre- and postsurgery together with IV sedation using midazolam and propofol. The Preincisional group received a single 50 mg dose of rofecoxib 1 h before surgery, the Postincisional group received rofecoxib 50 mg after the completion of surgery, and the Placebo group received a placebo tablet before surgery. Pain scores, the time to first opioid use, and 24-h analgesic use were recorded. Analgesic duration, defined as the time from completion of surgery until first opioid use, was significantly longer in those patients receiving pre- (803 ± 536 min) versus postincisional (461 ± 344 min) rofecoxib or placebo (318 ± 108 min). The 24 h acetaminophen/oxycodone use was less in the Preincisional group (1.5 ± 0.6 pills) versus the Postincisional group (3.3 ± 1.3 pills) or the Placebo group (5.5 ± 1.6 pills). Pain scores with movement were lower in the Preincisional group at all postoperative time intervals. We conclude that rofecoxib provides effective postoperative analgesia for arthroscopic meniscectomy. Further, the administration of rofecoxib 50 mg before surgery provides a longer duration of postoperative analgesia, less 24 h opioid use, and lower incidental pain scores compared with administering the drug after the completion of surgery.

IMPLICATIONS: The administration of rofecoxib 50 mg before arthroscopic knee surgery provides a longer duration of analgesia, less 24-h opioid use, and lower pain scores than administering the drug after the completion of surgery.

This article has been cited by other articles:

				P. F. White, H. Kehlet, and S. Liu Perioperative Analgesia: What Do We Still Know? Anesth. Analg., May 1, 2009; 108(5): 1364 - 1367. [Full Text] [PDF]

				T. Sun, O. Sacan, P. F. White, J. Coleman, R. J. Rohrich, and J. M. Kenkel Perioperative Versus Postoperative Celecoxib on Patient Outcomes After Major Plastic Surgery Procedures Anesth. Analg., March 1, 2008; 106(3): 950 - 958. [Abstract] [Full Text] [PDF]

				G. Riest, J. Peters, M. Weiss, S. Dreyer, P. D. Klassen, B. Stegen, A. Bello, and M. Eikermann Preventive effects of perioperative parecoxib on post-discectomy pain Br. J. Anaesth., February 1, 2008; 100(2): 256 - 262. [Abstract] [Full Text] [PDF]

				V. Martinez, A. Belbachir, A. Jaber, K. Cherif, A. Jamal, Y. Ozier, D. I. Sessler, M. Chauvin, and D. Fletcher The Influence of Timing of Administration on the Analgesic Efficacy of Parecoxib in Orthopedic Surgery Anesth. Analg., June 1, 2007; 104(6): 1521 - 1527. [Abstract] [Full Text] [PDF]

				P. F. White The Changing Role of Non-Opioid Analgesic Techniques in the Management of Postoperative Pain Anesth. Analg., November 1, 2005; 101(5S_Suppl): S5 - 22. [Abstract] [Full Text] [PDF]

				P. F. White Changing Role of COX-2 Inhibitors in the Perioperative Period: Is Parecoxib Really the Answer? Anesth. Analg., May 1, 2005; 100(5): 1306 - 1308. [Full Text] [PDF]

				A. Hadzic, P. E. Karaca, P. Hobeika, G. Unis, J. Dermksian, M. Yufa, R. Claudio, J. D. Vloka, A. C. Santos, and D. M. Thys Peripheral Nerve Blocks Result in Superior Recovery Profile Compared with General Anesthesia in Outpatient Knee Arthroscopy Anesth. Analg., April 1, 2005; 100(4): 976 - 981. [Abstract] [Full Text] [PDF]

				C. K.-S. Ong, P. Lirk, R. A. Seymour, and B. J. Jenkins The Efficacy of Preemptive Analgesia for Acute Postoperative Pain Management: A Meta-Analysis Anesth. Analg., March 1, 2005; 100(3): 757 - 773. [Abstract] [Full Text] [PDF]

				J. B. Dahl and S. Moiniche Pre-emptive analgesia Br. Med. Bull., December 13, 2004; 71(1): 13 - 27. [Abstract] [Full Text] [PDF]

				R. M. Pertusi Selective Cyclooxygenase Inhibition in Pain Management J Am Osteopath Assoc, November 1, 2004; 104(11_suppl): 19S - 24S. [Abstract] [Full Text] [PDF]

				E. F. Ekman and L. A. Koman Acute Pain Following Musculoskeletal Injuries and Orthopaedic Surgery. Mechanisms and Management J. Bone Joint Surg. Am., June 1, 2004; 86(6): 1316 - 1327. [Full Text] [PDF]

				I. D. Jackson, B. H. Heidemann, J. Wilson, I. Power, and R. D. Brown Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry Br. J. Anaesth., May 1, 2004; 92(5): 675 - 680. [Abstract] [Full Text] [PDF]

				H. Ma, J. Tang, P. F. White, A. Zaentz, R. H. Wender, A. Sloninsky, R. Naruse, R. Kariger, R. Quon, D. Wood, et al. Perioperative Rofecoxib Improves Early Recovery After Outpatient Herniorrhaphy Anesth. Analg., April 1, 2004; 98(4): 970 - 975. [Abstract] [Full Text] [PDF]

				R. S. Sinatra, Q. J. Shen, T. Halaszynski, M. A. Luther, and Y. Shaheen Preoperative Rofecoxib Oral Suspension as an Analgesic Adjunct After Lower Abdominal Surgery: The Effects on Effort-Dependent Pain and Pulmonary Function Anesth. Analg., January 1, 2004; 98(1): 135 - 140. [Abstract] [Full Text] [PDF]

				A. Buvanendran, J. S. Kroin, K. J. Tuman, T. R. Lubenow, D. Elmofty, M. Moric, and A. G. Rosenberg Effects of Perioperative Administration of a Selective Cyclooxygenase 2 Inhibitor on Pain Management and Recovery of Function After Knee Replacement: A Randomized Controlled Trial JAMA, November 12, 2003; 290(18): 2411 - 2418. [Abstract] [Full Text] [PDF]

				W. Joshi, N. R. Connelly, S. S. Reuben, M. Wolckenhaar, and N. Thakkar An Evaluation of the Safety and Efficacy of Administering Rofecoxib for Postoperative Pain Management Anesth. Analg., July 1, 2003; 97(1): 35 - 38. [Abstract] [Full Text] [PDF]

				N. M. Gajraj Cyclooxygenase-2 Inhibitors Anesth. Analg., June 1, 2003; 96(6): 1720 - 1738. [Full Text] [PDF]

				S. M. Gordon, J. S. Brahim, R. Dubner, L. M. McCullagh, C. Sang, and R. A. Dionne Attenuation of Pain in a Randomized Trial by Suppression of Peripheral Nociceptive Activity in the Immediate Postoperative Period Anesth. Analg., November 1, 2002; 95(5): 1351 - 1357. [Abstract] [Full Text] [PDF]

				D. J. Pavlin, C. Chen, D. A. Penaloza, N. L. Polissar, and F. P. Buckley Pain as a Factor Complicating Recovery and Discharge After Ambulatory Surgery Anesth. Analg., September 1, 2002; 95(3): 627 - 634. [Abstract] [Full Text] [PDF]